000			01967cam a2200349 a 4500
003			EG-GiCUC
005			20250223030247.0
008			100810s2010 ua dh f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.11.07.M.Sc.2010.Kh.E
100	0		_aKhaled Mabrouk Mohamed
245	1	0	_aEvaluation of serum osteoprotegerin and fetuin A in patients with chronic kidney disease / _cKhaled Mabrouk Mohamed ; Supervised Iris Guirguis Nessim , Amal Abdelwahab , Hanan Ali Madani
246	1	5	_aتقييم مستوى الفيتوين والاوستيوبرتوجيرين فى مصل مرضى الاعتلال الكلوى المزمن
260			_aCairo : _bKhaled Mabrouk Mohamed , _c2010
300			_a103P. : _bcharts , facsimiles ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology
520			_aCardiac complication are the major complication of end - stage renal disease . Although traditional risk factors such as diabetes mellitus hypertension are prevalent in end stage renal disease they are not sufficient to account for the high prevalence of cardiovascular mortality thus the search for other non traditional risk factors (such as fetuin A and osteoprotegrin) are potential new risk factors and provide evidence for using this inhibitors as surrogate markers for early recognition and early prevention and treatment of cardiovascular complications in patients with chronic renal diseases
530			_aIssued also as CD
653		4	_aFetuin A
653		4	_aOsteoprtegerin
653		4	_aVascular calcfication
700	0		_aAmal Abdelwahab , _eSupervisor
700	0		_aHanan Ali Madani , _eSupervisor
700	0		_aIris Guirguis Nessim , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aSoheir _eCataloger
942			_2ddc _cTH
999			_c31016 _d31016